NIH Teaming Up With Pharma Giants For New Treatments

The National Institute of Health announced Thursday that three pharmaceutical companies will be granting them access to industry compounds in an attempt to help the Institute spearhead new research into treatments for a wide variety of conditions.

“Americans are eagerly awaiting the next generation of cures and treatments to help them live longer and healthier lives,” Health and Human ServiceTo accelerate our nation’s therapeutic development process, it is essential that we forge strong, innovative, and strategic partnerships across government, academia and industry.”

The companies include AstraZeneca, Lilly and Pfizer and the NIH says that additional companies may eventually sign on. The compounds will be supplied to the NIH’s newly formed Natonal Center for Advancing Translational Sciences.

Tags: , , ,

About TRNS Washington Desk

View all posts by TRNS Washington Desk
TRNS Washington Desk
News updates from on and around Capitol Hill.

House Republicans To Meet Friday, Delaying Recess

Senate Democrats continue to fight to push through a $2.7 billion alternative to President Obama’s original $3.7 billion proposal.

Immigration Activists Arrested Outside White House

“Sí, se puede!” the crowd chanted. “Obama, don’t deport my mama!”

LISTEN: The World in Two Minutes – July 31, 2014

WorldIn2Logo

Israel presents evidence of rockets originating near Gaza schools, Argentina defaults on its national debt, and electric car sales double in Europe.

Our Government Needs To Sound Louder Warnings About Jihadists

Islamist terrorists no longer huddle and hide in caves in Afghanistan.

Anonymous Syrian Defector Reveals Assad’s Killing Machine

To protect his identity, “Caesar” wore a blue-hooded jacket, a baseball cap and sunglasses to hide his face.

Boehner: Obama Risks A “Legacy of Lawlessness”

“If the President takes these actions, he’ll be sealing the deal on his legacy of lawlessness,” Boehner said.